Browse by UCL people
Group by: Type | Date
Number of items: 4.
Article
De Angelis, F;
Connick, P;
Parker, RA;
Plantone, D;
Doshi, A;
John, N;
Stutters, J;
... Chataway, J; + view all
(2020)
Amiloride, fluoxetine or riluzole to reduce brain volume loss in secondary progressive multiple sclerosis: the MS-SMART four-arm RCT.
Efficacy and Mechanism Evaluation
, 7
(3)
pp. 1-72.
10.3310/eme07030.
|
 |
|
John, N;
Carroll, A;
Brownlee, WJ;
Chataway, J;
(2019)
Switching from natalizumab to alemtuzumab in patients with relapsing multiple sclerosis.
[Letter].
Journal of Neurology, Neurosurgery & Psychiatry
10.1136/jnnp-2019-320687.
(In press).
|
|
|
Solanky, BS;
John, NA;
DeAngelis, F;
Stutters, J;
Prados, F;
Schneider, T;
Parker, RA;
... MS-SMART Investigators, ./; + view all
(2020)
NAA is a Marker of Disability in Secondary-Progressive MS: A Proton MR Spectroscopic Imaging Study.
American Journal of Neuroradiology
10.3174/ajnr.A6809.
(In press).
|
Thesis
|
John, Nevin Alex;
(2021)
Investigating brain metabolism in multiple sclerosis to examine mechanisms of injury and disability using magnetic resonance spectroscopy.
Doctoral thesis (Ph.D), UCL (University College London).
|
